Status:

COMPLETED

Inspiratory Muscle Training in Post COVID-19 Infection Subjects

Lead Sponsor:

Universidade Federal de Pernambuco

Conditions:

COVID-19

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Long-term COVID has been considered a clinical condition in which the patient, after the critical period of the disease, still has systemic symptoms such as muscle weakness, inability to exercise, sle...

Detailed Description

The pulmonary function test will be used for the inclusion criteria and characterization of the sample. The Medical Microloop spirometer will be used. The test will be performed at least three times, ...

Eligibility Criteria

Inclusion

  • Patients of all genders, over 18 years of age, who are not undergoing any type of post-infection treatment, with a diagnosis through RT-PCR positive for the Coronavirus, who fall within the period of up to 10 days after hospital discharge will be included. .

Exclusion

  • Individuals with previous orthopedic, neurological problems or any cardiovascular or respiratory disease in their clinical history, pregnant women and patients in the active phase of infection for the coronavirus, or who cannot maintain proper positioning during the scintigraphy exam will be excluded pulmonary

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 31 2024

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT05282199

Start Date

March 1 2022

End Date

July 31 2024

Last Update

July 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidade Federal de Pernambuco

Recife, Pernambuco, Brazil